T Cell Depletion as an Alternative Approach for Patients 55 Years or Older Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic Malignancies-Reference-Cited by-同舟云学术

T Cell Depletion as an Alternative Approach for Patients 55 Years or Older Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic Malignancies

Published:2017-10 Issue:10 Volume:23 Page:1685-1694
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Jakubowski Ann A.,Petrlik Erica,Maloy Molly,Hilden Patrick,Papadopoulos Esperanza,Young James W.,Boulad Farid,Castro-Malaspina Hugo,Tamari Roni,Dahi Parastoo B.,Goldberg Jenna,Koehne Guenther,Perales Miguel-Angel,Sauter Craig S.,O'Reilly Richard J.,Giralt Sergio

Funder

National Cancer Institute, National Institutes of Health, and The Beatrice and Samuel A. Seaver Foundation for Cancer and Aging

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference54 articles.

1. Myeloablative conditioning is well tolerated by older patients receiving T-cell-depleted grafts;Novitzky;Bone Marrow Transplant,2005

2. CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission;Soiffer;Blood,1997

3. T- cell–depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease;Papadopoulos;Blood,1998

4. T cell– depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin;Jakubowski;Blood,2007

5. T cell– depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies;Jakubowski;Biol Blood Marrow Transplant,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transplantation and Cellular Therapy for Older Adults—The MSK Approach;Current Hematologic Malignancy Reports;2024-02-09

2. Ex vivo T‐cell depletion vs post‐transplant cyclophosphamide, sirolimus, and mycophenolate mofetil as graft‐vs‐host disease prophylaxis for allogeneic hematopoietic stem cell transplantation;European Journal of Haematology;2020-10-18

3. Combining the disease risk index and hematopoietic cell transplant co‐morbidity index provides a comprehensive prognostic model for CD34 + ‐selected allogeneic transplantation;ADVANCES IN CELL AND GENE THERAPY;2020-10-10

4. Ex Vivo T Cell-Depleted Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Myelogenous Leukemia in First and Second Remission: Long-Term Disease-Free Survival with a Significantly Reduced Risk of Graft-versus-Host Disease;Biology of Blood and Marrow Transplantation;2020-02

5. Checkpoint inhibitors in AML: are we there yet?;British Journal of Haematology;2019-12-06